Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Artelo Biosciences, Inc. (ARTL) had Income from Continuous Operations of $-3.12M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-3.12M |
|
-- |
|
-- |
|
$3.09M |
|
$-3.09M |
|
$-0.03M |
|
$-3.12M |
|
$-3.12M |
|
$-3.12M |
|
|
Income from Continuous Operations |
$-3.12M |
$-3.12M |
|
$-3.12M |
|
$-3.09M |
|
$-3.01M |
|
0.79M |
|
0.79M |
|
$-3.97 |
|
$-3.97 |
|
| Balance Sheet Financials | |
$1.83M |
|
-- |
|
$2.44M |
|
$4.27M |
|
$4.86M |
|
-- |
|
$0.04M |
|
$4.90M |
|
$-0.63M |
|
$-3.00M |
|
$-0.63M |
|
1.56M |
|
| Cash Flow Statement Financials | |
$-5.61M |
|
$-0.25M |
|
$5.26M |
|
$2.34M |
|
$1.72M |
|
$-0.62M |
|
$0.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.38 |
|
-- |
|
-- |
|
-- |
|
-1.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
492.89% |
|
104.10% |
|
-73.12% |
|
492.89% |
|
$-0.41 |
|
$-7.13 |
|
$-7.13 |
|